LDP

L-DOPAMINE

Created:	1999-07-08
Last modified:	2020-06-05

Find Related PDB Entry
33 entries where LDP is found as a standalone ligand2 entries where LDP is covalently linked to polymer or other heterogen groups

Help Find related ligands:
Similar Ligands (Stereospecific) Similar Ligands (including Stereoisomers) Similar Ligands (Quick Screen) Similar Ligands (Substructure Stereospecific) Similar Ligands (Substructure including Stereoisomers)

Help

Find related ligands:

Similar Ligands (Stereospecific) Similar Ligands (including Stereoisomers) Similar Ligands (Quick Screen) Similar Ligands (Substructure Stereospecific) Similar Ligands (Substructure including Stereoisomers)

Chemical Details
Formal Charge	0
Atom Count	22
Chiral Atom Count	0
Bond Count	22
Aromatic Bond Count	6

WebGL does not seem to be available.

This can be caused by an outdated browser, graphics card driver issue, or bad weather. Sometimes, just restarting the browser helps. Also, make sure hardware acceleration is enabled in your browser.

For a list of supported browsers, refer to http://caniuse.com/#feat=webgl.

Toggle Hydrogen Toggle Labels

Chemical Component Summary
Name	L-DOPAMINE
Synonyms	DOPAMINE
Systematic Name (OpenEye OEToolkits)	4-(2-aminoethyl)benzene-1,2-diol
Formula	C₈ H₁₁ N O₂
Molecular Weight	153.178
Type	NON-POLYMER

Chemical Descriptors
Type	Program	Version	Descriptor
SMILES	ACDLabs	10.04	Oc1ccc(cc1O)CCN
SMILES	CACTVS	3.341	NCCc1ccc(O)c(O)c1
SMILES	OpenEye OEToolkits	1.5.0	c1cc(c(cc1CCN)O)O
Canonical SMILES	CACTVS	3.341	NCCc1ccc(O)c(O)c1
Canonical SMILES	OpenEye OEToolkits	1.5.0	c1cc(c(cc1CCN)O)O
InChI	InChI	1.03	InChI=1S/C8H11NO2/c9-4-3-6-1-2-7(10)8(11)5-6/h1-2,5,10-11H,3-4,9H2
InChIKey	InChI	1.03	VYFYYTLLBUKUHU-UHFFFAOYSA-N

Drug Info: DrugBank

DrugBank ID	DB00988
Name	Dopamine
Groups	approved
Description	One of the catecholamine neurotransmitters in the brain. It is derived from tyrosine and is the precursor to norepinephrine and epinephrine. Dopamine is a major transmitter in the extrapyramidal system of the brain, and important in regulating movement. A family of receptors (receptors, dopamine) mediate its action.
Synonyms	4-(2-aminoethyl)catechol 4-(2-Aminoethyl)benzene-1,2-diol Dopaminum 3-Hydroxytyramine Oxytyramine Dopamine hydrochloride 4-(2-aminoethyl)pyrocatechol 4-(2-aminoethyl)-1,2-benzenediol Dopamine Dopamina 2-(3,4-dihydroxyphenyl)ethylamine 3,4-Dihydroxyphenethylamine
Brand Names	Dopamine HCl Inj 4% Dopamine Hydrochloride and 5% Dextrose Injection USP Dopamine HCl Dopamine Hci In 5% Dextrose DOPamine Hydrochloride Dopamine Hydrochloride and Dextrose Dopamine Hydrochloride DOPamine Hydrochloride and Dextrose Dopamine HCl 3.2mg/ml Dextrose 5% Inj USP Dopamine Hydrochloride in Dextrose Myocard-DX Dopamine Intropin Injection 40mg/ml Dopamine HCl 0.8mg/ml Dextrose 5% Inj USP Dopamine HCl 1.6mg/ml Dextrose 5% Inj USP DOPamine HYDROCHLORIDE AND DEXTROSE Neoatricon Dopamine Hci
Indication	For the correction of hemodynamic imbalances present in the shock syndrome due to myocardial infarction, trauma, endotoxic septicemia, open-heart surgery, renal failure, and chronic cardiac decompensation as in congestive failure
Categories	Adrenergic and Dopaminergic Agents Agents producing tachycardia Agents that produce hypertension Amines Autonomic Agents Benzene Derivatives Biogenic Amines Biogenic Monoamines Cardiac Stimulants Excl. Cardiac Glycosides Cardiac Therapy Cardiotonic Agents Cardiovascular Agents Catecholamines Catechols Compounds used in a research, industrial, or household setting COMT Substrates Dopamine Agents Dopamine, metabolism Drugs that are Mainly Renally Excreted Monoamine Oxidase A Substrates Neurotransmitter Agents OCT1 substrates OCT2 Inhibitors OCT2 Substrates Peripheral Nervous System Agents Phenols Protective Agents Selective Beta 1-adrenergic Agonists Sympathomimetics
ATC-Code	C01CA04
CAS number	51-61-6

Drug Targets

Name	Target Sequence	Pharmacological Action	Actions
D(2) dopamine receptor	MDPLNLSWYDDDLERQNWSRPFNGSDGKADRPHYNYYATLLTLLIAVIVF...	unknown	agonist
D(1A) dopamine receptor	MRTLNTSAMDGTGLVVERDFSVRILTACFLSLLILSTLLGNTLVCAAVIR...	unknown	agonist
D(1B) dopamine receptor	MLPPGSNGTAYPGQFALYQQLAQGNAVGGSAGAPPLGPSQVVTACLLTLL...	unknown	agonist
D(3) dopamine receptor	MASLSQLSGHLNYTCGAENSTGASQARPHAYYALSYCALILAIVFGNGLV...	unknown	agonist
D(4) dopamine receptor	MGNRSTADADGLLAGRGPAAGASAGASAGLAGQGAAALVGGVLLIGAVLA...	unknown	agonist
Sodium-dependent dopamine transporter	MSKSKCSVGLMSSVVAPAKEPNAVGPKEVELILVKEQNGVQLTSSTLTNP...	unknown	inducer
Dopamine beta-hydroxylase	MPALSRWASLPGPSMREAAFMYSTAVAIFLVILVAALQGSAPRESPLPYH...	unknown	ligand
5-hydroxytryptamine receptor 1A	MDVLSPGQGNNTTSPPAPFETGGNTTGISDVTVSYQVITSLLLGTLIFCA...	unknown	binder
5-hydroxytryptamine receptor 7	MMDVNSSGRPDLYGHLRSFLLPEVGRGLPDLSPDGGADPVAGSWAPHLLS...	unknown	binder
D(1) dopamine receptor	MRTLNTSAMDGTGLVVERDFSVRILTACFLSLLILSTLLGNTLVCAAVIR...	unknown	agonist
Sodium-dependent noradrenaline transporter	MLLARMNPQVQPENNGADTGPEQPLRARKTAELLVVKERNGVQCLLAPRD...	unknown	inhibitor
Sodium-dependent serotonin transporter	METTPLNSQKQLSACEDGEDCQENGVLQKVVPTPGDKVESGQISNGYSAV...	unknown	inhibitor
5-hydroxytryptamine receptor 3A	MLLWVQQALLALLLPTLLAQGEARRSRNTTRPALLRLSDYLLTNYRKGVR...	unknown
5-hydroxytryptamine receptor 3B	MLSSVMAPLWACILVAAGILATDTHHPQDSALYHLSKQLLQKYHKEVRPV...	unknown
Superoxide dismutase [Cu-Zn]	MATKAVCVLKGDGPVQGIINFEQKESNGPVKVWGSIKGLTEGLHGFHVHE...	unknown
Synaptic vesicular amine transporter	MALSELALVRWLQESRRSRKLILFIVFLALLLDNMLLTVVVPIIPSYLYS...	unknown
Dopamine beta-hydroxylase	MPALSRWASLPGPSMREAAFMYSTAVAIFLVILVAALQGSAPRESPLPYH...	unknown	substrate
Amine oxidase [flavin-containing] A	MENQEKASIAGHMFDVVVIGGGISGLSAAKLLTEYGVSVLVLEARDRVGG...	unknown	substrate
Amine oxidase [flavin-containing] B	MSNKCDVVVVGGGISGMAAAKLLHDSGLNVVVLEARDRVGGRTYTLRNQK...	unknown	substrate
Catechol O-methyltransferase	MPEAPPLLLAAVLLGLVLLVVLLLLLRHWGWGLCLIGWNEFILQPIHNLL...	unknown	substrate
Solute carrier family 22 member 2	MPTTVDDVLEHGGEFHFFQKQMFFLLALLSATFAPIYVGIVFLGFTPDHR...	unknown	substrate,inhibitor
Solute carrier family 22 member 1	MPTVDDILEQVGESGWFQKQAFLILCLLSAAFAPICVGIVFLGFTPDHHC...	unknown	substrate
Solute carrier family 22 member 3	MPSFDEALQRVGEFGRFQRRVFLLLCLTGVTFAFLFVGVVFLGTQPDHYW...	unknown	inhibitor
Organic cation/carnitine transporter 2	MRDYDEVTAFLGEWGPFQRLIFFLLSASIIPNGFTGLSSVFLIATPEHRC...	unknown	inhibitor
POU domain, class 5, transcription factor 1	MAGHLASDFAFSPPPGGGGDGPGGPEPGWVDPRTWLSFQGPPGGPGIGPG...	unknown	substrate
View More

Drug Info/Drug Targets: DrugBank 3.0: a comprehensive resource for 'omics' research on drugs. Knox C, Law V, Jewison T, Liu P, Ly S, Frolkis A, Pon A, Banco K, Mak C, Neveu V, Djoumbou Y, Eisner R, Guo AC, Wishart DS. Nucleic Acids Res. 2011 Jan; 39 (Database issue):D1035-41. | PMID:21059682